Daclatasvir and sofosbuvir with ribavirin cures 90% of people with genotype 3 hepatitis C
Tenofovir during pregnancy reduces risk of mother-to-child hepatitis B virus transmission
UK’s latest HIV figures show the need to scale up HIV testing and prevention
New AbbVie hepatitis C combination cures 93 to 97% with genotype 3
Sofosbuvir/ledipasvir plus vedroprevir shows 96% response rate for hard-to-treat genotype 1 hepatitis C patients
Barcelona clinic study counts how many gay men might benefit from PrEP
Sofosbuvir/velpatasvir shows high cure rates for all HCV genotypes, works well for patients with liver decompensation
Sofosbuvir & ravidasvir delivers high sustained response rates for genotype 4 hepatitis C patients
